Hock, C. et al. Generation of anti-amyloid antibodies by vaccination of patients with Alzheimer's disease. Nature Med. 8, 1270–1275 (2002).
McLaurin, J.A. et al. Therapeutically effective anti-Aβ antibodies target Aβ residues 4–10 and inhibit cytotoxicity and fibrillogenesis. Nature Med. 8, 1263–1269 (2002).
Check, E. Nerve inflammation halts trial for Alzheimer's drug. Nature 415, 462 (2002).
Haass, C. & Steiner, H. Alzheimer's disease γ-secretase, a multicomponent complex involving presenilin proteases of the GxGD type. Trends Cell Biol. (in the press).
Walsh, D.M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002).
Weihofen, A., Binns, K., Lemberg, M.K., Ashman, K. & Martoglio, B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296, 2215–2218 (2002).
Cai, H. et al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nature Neurosci. 4, 233–234 (2001).
Luo, Y. et al. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nature Neurosci. 4, 231–232 (2001).
Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916–919 (2000).
DeMattos, R.B. et al. Peripheral anti-Aβ antibody alters CNS and plasma A β clearance and decreases brain A β burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 8850–8855 (2001).
Solomon, B., Koppel, R., Frankel, D. & Hanan-Aharon, E. Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. USA 94, 4109–4112 (1997).
Morgan, D. et al. A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982–985 (2000).
Janus, C. et al. A β peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979–982 (2000).
Smith, M.A., Atwood, C.S., Joseph, J.A. & Perry, G. Predicting the failure of amyloid-β vaccine. Lancet 359, 1864–1865 (2002).